Carisma Therapeutics, Inc. Stock
Stocks
CARM
US14216R1014
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
11:31:00 2026-06-02 EDT
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | -.--% |
|
-95.65% | -99.77% |
| Market Cap | 1.8M 1.54M 1.44M 1.32M 2.49M 172M 2.52M 17.04M 6.63M 86.55M 6.76M 6.61M 287M | P/E 2023 |
-1.13x | P/E 2024 | -0.29x |
|---|---|---|---|---|---|
| Enterprise Value | -14.55M -12.47M -11.69M -10.67M -20.14M -1.39B -20.34M -138M -53.66M -700M -54.65M -53.46M -2.32B | EV / Sales 2023 |
2,933,403x | EV / Sales 2024 | 57,658x |
| Free-Float |
76.96% | Yield 2023 * |
-
| Yield 2024 | - |
| 1 week | -95.65% | ||
| Current month | -96.00% | ||
| 1 month | -97.78% | ||
| 6 months | -99.76% | ||
| Current year | -99.77% |
| 1 week | 0 |  | 0 |
| 1 month | 0 | | 0 |
| Current year | 0 | | 0.05 |
| 1 year | 0 | | 0.56 |
| 3 years | 0 | | 7.14 |
| 5 years | 0 | | 9.77 |
| 10 years | 0 | | 9.77 |
| Manager | Title | Age | Since |
|---|---|---|---|
Craig Jalbert
CEO | Chief Executive Officer | 64 | 2025-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Craig Jalbert
BRD | Director/Board Member | 64 | 2025-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 10/7/25 | Fiscal year | Founder | 170,946 | 0.4095% | ||
| 10/1/25 | Sell | Founder | 484,347 | 1.1601% | ||
| 1/28/25 | Free | Chief Executive Officer | 500,000 | 1.1976% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -95.65% | -99.96% | -100.00% | 50.21K | |
| +3.31% | -3.70% | +61.03% | +103.64% | 71.35B | |
| +1.74% | +1.06% | +49.02% | +87.38% | 64.17B | |
| +1.09% | +22.96% | +8.55% | -3.03% | 28.65B | |
| -0.07% | -3.56% | -3.45% | +467.26% | 27.06B | |
| -3.26% | +5.53% | +54.97% | +11.71% | 27.33B | |
| +3.98% | +4.37% | +39.47% | -14.65% | 20.47B | |
| +1.02% | +6.43% | +269.42% | +420.34% | 19.36B | |
| +0.10% | 0.00% | +7.80% | +542.33% | 15.96B | |
| +3.98% | +6.78% | +49.66% | +157.94% | 14.05B | |
| Average | +1.19% | +4.02% | +43.65% | +167.29% | 28.84B | |
| Weighted average by Cap. | +1.55% | +3.31% | +55.48% | +154.62% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 14.92 12.78 11.98 10.94 20.65 1.42K 20.85 141.3 55.01 717.58 56.02 54.8 2.38K | 19.63 16.82 15.76 14.4 27.17 1.87K 27.44 185.94 72.38 944.27 73.71 72.11 3.13K |
| Net income | -86.88M -74.45M -69.76M -63.72M -120M -8.28B -121M -823M -320M -4.18B -326M -319M -13.84B | -60.48M -51.82M -48.56M -44.36M -83.71M -5.77B -84.53M -573M -223M -2.91B -227M -222M -9.63B |
| Net Debt | -74.48M -63.82M -59.8M -54.63M -103M -7.1B -104M -705M -275M -3.58B -280M -274M -11.86B | -16.35M -14.01M -13.13M -11.99M -22.64M -1.56B -22.86M -155M -60.29M -787M -61.4M -60.06M -2.6B |
Employees
46
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-25 | US$0.001200 | -47.83% | 3,223 |
| 26-08-24 | US$0.002300 | +91.67% | 44,571 |
| 26-08-21 | US$0.001200 | -47.83% | 201 |
| 26-08-20 | US$0.002300 | +4.55% | 752 |
| 26-08-19 | US$0.002200 | -4.35% | 17,336 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CARM Stock
Select your edition
All financial news and data tailored to specific country editions
